PS, Y., CL, C., CP, H., YH, L., & KH, T. (2018). An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. Dove Medical Press.
Chicago Style (17th ed.) CitationPS, Yang, Chen CL, Hou CP, Lin YH, and Tsui KH. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.
MLA (8th ed.) CitationPS, Yang, et al. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.